annual CFI:
-$3.77B-$628.30M(-20.00%)Summary
- As of today (August 23, 2025), VRTX annual cash flow from investing activities is -$3.77 billion, with the most recent change of -$628.30 million (-20.00%) on December 31, 2024.
- During the last 3 years, VRTX annual CFI has fallen by -$3.43 billion (-1005.90%).
- VRTX annual CFI is now -1030.48% below its all-time high of $405.17 million, reached on December 31, 2007.
Performance
VRTX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$484.50M-$428.70M(-768.28%)Summary
- As of today (August 23, 2025), VRTX quarterly cash flow from investing activities is -$484.50 million, with the most recent change of -$428.70 million (-768.28%) on June 30, 2025.
- Over the past year, VRTX quarterly CFI has dropped by -$20.80 million (-4.49%).
- VRTX quarterly CFI is now -219.35% below its all-time high of $405.95 million, reached on March 31, 2011.
Performance
VRTX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$1.71B-$20.80M(-1.23%)Summary
- As of today (August 23, 2025), VRTX TTM cash flow from investing activities is -$1.71 billion, with the most recent change of -$20.80 million (-1.23%) on June 30, 2025.
- Over the past year, VRTX TTM CFI has increased by +$1.89 billion (+52.55%).
- VRTX TTM CFI is now -445.27% below its all-time high of $495.33 million, reached on June 30, 2015.
Performance
VRTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VRTX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.0% | -4.5% | +52.5% |
| 3 y3 years | -1005.9% | -687.8% | -471.1% |
| 5 y5 years | -205.2% | -773.7% | -64.1% |
VRTX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1074.1% | at low | -375.9% | +77.3% | -471.1% | +55.4% |
| 5 y | 5-year | -3893.2% | at low | -298.8% | +77.3% | -1820.7% | +55.4% |
| alltime | all time | -1030.5% | at low | -219.3% | +77.3% | -445.3% | +55.4% |
VRTX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$484.50M(+768.3%) | -$1.71B(+1.2%) |
| Mar 2025 | - | -$55.80M(-93.2%) | -$1.69B(-55.2%) |
| Dec 2024 | -$3.77B(+20.0%) | -$821.90M(+136.2%) | -$3.77B(-1.7%) |
| Sep 2024 | - | -$348.00M(-25.0%) | -$3.83B(+6.4%) |
| Jun 2024 | - | -$463.70M(-78.3%) | -$3.60B(+4.6%) |
| Mar 2024 | - | -$2.14B(+141.0%) | -$3.44B(+9.6%) |
| Dec 2023 | -$3.14B(+878.4%) | -$886.50M(+653.2%) | -$3.14B(+51.1%) |
| Sep 2023 | - | -$117.70M(-61.3%) | -$2.08B(-11.4%) |
| Jun 2023 | - | -$303.90M(-83.4%) | -$2.35B(+11.5%) |
| Mar 2023 | - | -$1.83B(-1144.2%) | -$2.10B(+555.2%) |
| Dec 2022 | -$321.10M(-5.8%) | $175.60M(-145.7%) | -$321.10M(-49.1%) |
| Sep 2022 | - | -$384.20M(+524.7%) | -$630.70M(+110.6%) |
| Jun 2022 | - | -$61.50M(+20.6%) | -$299.45M(-5.7%) |
| Mar 2022 | - | -$51.00M(-61.9%) | -$317.59M(-6.8%) |
| Dec 2021 | -$340.90M(-443.0%) | -$134.00M(+153.1%) | -$340.90M(-1025.2%) |
| Sep 2021 | - | -$52.95M(-33.5%) | $36.84M(-123.3%) |
| Jun 2021 | - | -$79.64M(+7.2%) | -$158.14M(+2300.8%) |
| Mar 2021 | - | -$74.31M(-130.5%) | -$6.59M(-106.6%) |
| Dec 2020 | $99.39M(-108.0%) | $243.75M(-198.3%) | $99.39M(-109.5%) |
| Sep 2020 | - | -$247.94M(-444.8%) | -$1.04B(-0.1%) |
| Jun 2020 | - | $71.91M(+127.1%) | -$1.04B(-10.5%) |
| Mar 2020 | - | $31.67M(-103.5%) | -$1.16B(-5.7%) |
| Dec 2019 | -$1.24B(+535.9%) | -$896.99M(+260.2%) | -$1.24B(+232.7%) |
| Sep 2019 | - | -$249.00M(+396.1%) | -$371.33M(+115.6%) |
| Jun 2019 | - | -$50.19M(+28.2%) | -$172.22M(-27.7%) |
| Mar 2019 | - | -$39.14M(+18.6%) | -$238.33M(+22.7%) |
| Dec 2018 | -$194.26M(-54.0%) | -$33.01M(-33.8%) | -$194.26M(+6.3%) |
| Sep 2018 | - | -$49.89M(-57.1%) | -$182.66M(-38.4%) |
| Jun 2018 | - | -$116.30M(-2457.6%) | -$296.45M(+15.6%) |
| Mar 2018 | - | $4.93M(-123.0%) | -$256.44M(-39.3%) |
| Dec 2017 | -$422.35M(-676.0%) | -$21.41M(-86.9%) | -$422.35M(+132.8%) |
| Sep 2017 | - | -$163.68M(+114.6%) | -$181.43M(-3768.2%) |
| Jun 2017 | - | -$76.28M(-52.6%) | $4.95M(-72.0%) |
| Mar 2017 | - | -$160.98M(-173.3%) | $17.69M(-75.9%) |
| Dec 2016 | $73.32M(-71.5%) | $219.51M(+867.1%) | $73.32M(-127.3%) |
| Sep 2016 | - | $22.70M(-135.7%) | -$268.88M(-31.5%) |
| Jun 2016 | - | -$63.54M(-39.7%) | -$392.51M(+676.8%) |
| Mar 2016 | - | -$105.34M(-14.1%) | -$50.53M(-118.8%) |
| Dec 2015 | $257.17M(+255.6%) | -$122.69M(+21.6%) | $268.86M(-26.1%) |
| Sep 2015 | - | -$100.94M(-136.2%) | $363.85M(-26.5%) |
| Jun 2015 | - | $278.44M(+30.1%) | $495.33M(+61.5%) |
| Mar 2015 | - | $214.04M(-872.7%) | $306.77M(+324.2%) |
| Dec 2014 | $72.32M(-188.2%) | -$27.70M(-190.7%) | $72.32M(+143.7%) |
| Sep 2014 | - | $30.55M(-66.0%) | $29.68M(-28.4%) |
| Jun 2014 | - | $89.88M(-540.4%) | $41.44M(-171.6%) |
| Mar 2014 | - | -$20.41M(-71.0%) | -$57.85M(-29.5%) |
| Dec 2013 | -$82.01M(-79.9%) | -$70.34M(-266.3%) | -$82.01M(+764.3%) |
| Sep 2013 | - | $42.31M(-549.5%) | -$9.49M(-94.2%) |
| Jun 2013 | - | -$9.41M(-78.9%) | -$164.09M(-27.6%) |
| Mar 2013 | - | -$44.57M(-2138.9%) | -$226.72M(-44.4%) |
| Dec 2012 | -$407.71M(-291.9%) | $2.19M(-101.9%) | -$407.71M(-48.9%) |
| Sep 2012 | - | -$112.30M(+55.9%) | -$797.67M(+20.1%) |
| Jun 2012 | - | -$72.04M(-68.1%) | -$663.93M(+58.4%) |
| Mar 2012 | - | -$225.56M(-41.8%) | -$419.10M(-297.3%) |
| Dec 2011 | $212.41M(+2809.4%) | -$387.78M(-1908.2%) | $212.41M(-50.7%) |
| Sep 2011 | - | $21.45M(-87.6%) | $430.49M(+5.9%) |
| Jun 2011 | - | $172.79M(-57.4%) | $406.63M(+48.1%) |
| Mar 2011 | - | $405.95M(-339.2%) | $274.49M(+3659.6%) |
| Dec 2010 | $7.30M(-101.4%) | -$169.69M(+6929.6%) | $7.30M(-102.0%) |
| Sep 2010 | - | -$2.41M(-105.9%) | -$370.78M(+13.8%) |
| Jun 2010 | - | $40.65M(-70.7%) | -$325.84M(-27.6%) |
| Mar 2010 | - | $138.76M(-125.3%) | -$450.15M(-11.5%) |
| Dec 2009 | -$508.73M(+41.1%) | -$547.78M(-1388.1%) | -$508.73M(+1516.6%) |
| Sep 2009 | - | $42.52M(-150.8%) | -$31.47M(-82.3%) |
| Jun 2009 | - | -$83.66M(-204.3%) | -$177.85M(+37.8%) |
| Mar 2009 | - | $80.18M(-213.7%) | -$129.07M(-64.2%) |
| Dec 2008 | -$360.65M | -$70.52M(-32.1%) | -$360.65M(+146.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | -$103.86M(+197.8%) | -$146.40M(-205.5%) |
| Jun 2008 | - | -$34.87M(-77.0%) | $138.72M(+188.4%) |
| Mar 2008 | - | -$151.40M(-205.3%) | $48.10M(-88.1%) |
| Dec 2007 | $405.17M(-294.4%) | $143.74M(-20.7%) | $405.17M(-2247.1%) |
| Sep 2007 | - | $181.26M(-244.4%) | -$18.87M(-89.5%) |
| Jun 2007 | - | -$125.50M(-161.0%) | -$179.42M(+297.9%) |
| Mar 2007 | - | $205.66M(-173.4%) | -$45.09M(-78.4%) |
| Dec 2006 | -$208.47M(>+9900.0%) | -$280.30M(-1453.3%) | -$208.47M(-624.2%) |
| Sep 2006 | - | $20.71M(+134.6%) | $39.77M(-235.6%) |
| Jun 2006 | - | $8.83M(-79.1%) | -$29.33M(-861.6%) |
| Mar 2006 | - | $42.29M(-231.9%) | $3.85M(-322.3%) |
| Dec 2005 | -$1.73M(-101.6%) | -$32.06M(-33.7%) | -$1.73M(-102.5%) |
| Sep 2005 | - | -$48.38M(-215.2%) | $68.22M(-49.4%) |
| Jun 2005 | - | $42.01M(+14.5%) | $134.75M(-2.0%) |
| Mar 2005 | - | $36.70M(-3.1%) | $137.50M(+28.0%) |
| Dec 2004 | $107.43M(-10.2%) | $37.89M(+108.9%) | $107.43M(+5.5%) |
| Sep 2004 | - | $18.14M(-59.5%) | $101.82M(+51.2%) |
| Jun 2004 | - | $44.76M(+574.3%) | $67.32M(+367.9%) |
| Mar 2004 | - | $6.64M(-79.4%) | $14.39M(-88.0%) |
| Dec 2003 | $119.58M(-849.2%) | $32.28M(-297.3%) | $119.58M(+21.4%) |
| Sep 2003 | - | -$16.36M(+100.1%) | $98.50M(-10.8%) |
| Jun 2003 | - | -$8.18M(-107.3%) | $110.48M(+38.1%) |
| Mar 2003 | - | $111.84M(+898.4%) | $80.00M(-601.2%) |
| Dec 2002 | -$15.96M(-89.0%) | $11.20M(-355.7%) | -$15.96M(-73.1%) |
| Sep 2002 | - | -$4.38M(-88.7%) | -$59.39M(+277.3%) |
| Jun 2002 | - | -$38.66M(-343.5%) | -$15.74M(-49.4%) |
| Mar 2002 | - | $15.87M(-149.3%) | -$31.12M(-78.6%) |
| Dec 2001 | -$145.09M(-38.6%) | -$32.23M(-182.1%) | -$145.09M(-44.0%) |
| Sep 2001 | - | $39.27M(-172.7%) | -$259.22M(-24.9%) |
| Jun 2001 | - | -$54.03M(-44.9%) | -$345.26M(+3.9%) |
| Mar 2001 | - | -$98.10M(-33.0%) | -$332.27M(+40.6%) |
| Dec 2000 | -$236.33M(-749.9%) | -$146.36M(+212.9%) | -$236.33M(+160.5%) |
| Sep 2000 | - | -$46.78M(+14.0%) | -$90.72M(+343.1%) |
| Jun 2000 | - | -$41.03M(+1799.6%) | -$20.47M(-184.4%) |
| Mar 2000 | - | -$2.16M(+187.6%) | $24.27M(-33.3%) |
| Dec 1999 | $36.36M(-278.3%) | -$751.00K(-103.2%) | $36.36M(+62.9%) |
| Sep 1999 | - | $23.47M(+532.6%) | $22.33M(+128.4%) |
| Jun 1999 | - | $3.71M(-62.6%) | $9.78M(-216.6%) |
| Mar 1999 | - | $9.93M(-167.2%) | -$8.39M(-58.9%) |
| Dec 1998 | -$20.39M(-82.8%) | -$14.79M(-235.4%) | -$20.39M(-81.4%) |
| Sep 1998 | - | $10.92M(-175.6%) | -$109.51M(-15.8%) |
| Jun 1998 | - | -$14.45M(+596.5%) | -$130.03M(+451.5%) |
| Mar 1998 | - | -$2.08M(-98.0%) | -$23.57M(-80.2%) |
| Dec 1997 | -$118.81M(+194.5%) | -$103.90M(+982.3%) | -$118.80M(+525.3%) |
| Sep 1997 | - | -$9.60M(-110.4%) | -$19.00M(-62.5%) |
| Jun 1997 | - | $92.00M(-194.6%) | -$50.60M(-63.2%) |
| Mar 1997 | - | -$97.30M(+2273.2%) | -$137.40M(+240.1%) |
| Dec 1996 | -$40.35M(+39.1%) | -$4.10M(-90.0%) | -$40.40M(-16.5%) |
| Sep 1996 | - | -$41.20M(-892.3%) | -$48.40M(+545.3%) |
| Jun 1996 | - | $5.20M(-1833.3%) | -$7.50M(-44.9%) |
| Mar 1996 | - | -$300.00K(-97.5%) | -$13.60M(-53.1%) |
| Dec 1995 | -$29.02M(+105.7%) | -$12.10M(+3933.3%) | -$29.00M(+835.5%) |
| Sep 1995 | - | -$300.00K(-66.7%) | -$3.10M(-111.4%) |
| Jun 1995 | - | -$900.00K(-94.3%) | $27.20M(-2042.9%) |
| Mar 1995 | - | -$15.70M(-213.8%) | -$1.40M(-90.1%) |
| Dec 1994 | -$14.10M(-310.9%) | $13.80M(-54.0%) | -$14.10M(-42.0%) |
| Sep 1994 | - | $30.00M(-201.7%) | -$24.30M(-46.5%) |
| Jun 1994 | - | -$29.50M(+3.9%) | -$45.40M(+66.9%) |
| Mar 1994 | - | -$28.40M(-888.9%) | -$27.20M(-506.0%) |
| Dec 1993 | $6.69M(-171.1%) | $3.60M(-59.6%) | $6.70M(-211.7%) |
| Sep 1993 | - | $8.90M(-178.8%) | -$6.00M(-13.0%) |
| Jun 1993 | - | -$11.30M(-305.5%) | -$6.90M(+155.6%) |
| Mar 1993 | - | $5.50M(-160.4%) | -$2.70M(-71.3%) |
| Dec 1992 | -$9.41M(-62.7%) | -$9.10M(-213.8%) | -$9.40M(+3033.3%) |
| Sep 1992 | - | $8.00M(-212.7%) | -$300.00K(-96.4%) |
| Jun 1992 | - | -$7.10M(+491.7%) | -$8.30M(+591.7%) |
| Mar 1992 | - | -$1.20M | -$1.20M |
| Dec 1991 | -$25.22M | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual cash flow from investing activities?
- What is the all time high annual CFI for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual CFI year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly CFI year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM cash flow from investing activities?
- What is the all time high TTM CFI for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM CFI year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual cash flow from investing activities?
The current annual CFI of VRTX is -$3.77B
What is the all time high annual CFI for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual cash flow from investing activities is $405.17M
What is Vertex Pharmaceuticals Incorporated annual CFI year-on-year change?
Over the past year, VRTX annual cash flow from investing activities has changed by -$628.30M (-20.00%)
What is Vertex Pharmaceuticals Incorporated quarterly cash flow from investing activities?
The current quarterly CFI of VRTX is -$484.50M
What is the all time high quarterly CFI for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly cash flow from investing activities is $405.95M
What is Vertex Pharmaceuticals Incorporated quarterly CFI year-on-year change?
Over the past year, VRTX quarterly cash flow from investing activities has changed by -$20.80M (-4.49%)
What is Vertex Pharmaceuticals Incorporated TTM cash flow from investing activities?
The current TTM CFI of VRTX is -$1.71B
What is the all time high TTM CFI for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM cash flow from investing activities is $495.33M
What is Vertex Pharmaceuticals Incorporated TTM CFI year-on-year change?
Over the past year, VRTX TTM cash flow from investing activities has changed by +$1.89B (+52.55%)